Table 1.
The baseline characteristics of patients with CRC according to the expression levels of FEN1 in TCGA-COAD cohort.
| Characteristics | Low FEN1 | High FEN1 | P-value |
|---|---|---|---|
| Sample size | 198 | 198 | |
| T stage, n (%) | .445 | ||
| T1 | 6 | 3 | |
| T2 | 26 | 33 | |
| T3 | 146 | 137 | |
| T4 | 20 | 25 | |
| N stage, n (%) | .695 | ||
| N0 | 107 | 114 | |
| N1 | 52 | 45 | |
| N2 | 39 | 39 | |
| M stage, n (%) | .026 | ||
| M0 | 153 | 114 | |
| M1 | 22 | 36 | |
| MX | 23 | 18 | |
| Pathologic stage, n (%) | .279 | ||
| I | 33 | 38 | |
| II | 74 | 85 | |
| III | 64 | 54 | |
| IV | 31 | 21 | |
| Gender, n (%) | .131 | ||
| Female | 114 | 99 | |
| Male | 84 | 99 | |
| Age (years), n (%) | .328 | ||
| >60 | 132 | 141 | |
| ≤60 | 66 | 57 | |
| Outcomes, n (%) | .613 | ||
| Dead | 37 | 41 | |
| Alive | 161 | 157 |
FEN1 = flap endonuclease 1, TCGA = The Cancer Genome Atlas.